These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3501703

  • 1. In vitro susceptibility of Haemophilus influenzae to cefixime.
    Powell M, Williams JD.
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1841-2. PubMed ID: 3501703
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activity of cefixime against Haemophilus influenzae isolates, including ampicillin-resistant, non-beta-lactamase-producing isolates, from pediatric patients.
    Mortensen JE, Himes SL.
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1456-8. PubMed ID: 2386375
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
    Bergeron MG, Lavoie GY, Boucher FD.
    J Antimicrob Chemother; 1987 Nov; 20(5):663-9. PubMed ID: 3501422
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S, Pellegrino MB, D'Amico G, Privitera A, Privitera O, Maccarrone G, Russo G, Nicoletti G.
    Chemotherapy; 1992 Nov; 38(1):36-45. PubMed ID: 1618002
    [Abstract] [Full Text] [Related]

  • 10. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
    García-Cobos S, Campos J, Lázaro E, Román F, Cercenado E, García-Rey C, Pérez-Vázquez M, Oteo J, de Abajo F.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2564-73. PubMed ID: 17470649
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
    Knapp CC, Sierra-Madero J, Washington JA.
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1896-8. PubMed ID: 3245701
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
    Yamada T, Yokota Y, Ikeda F, Mine Y, Kitada T.
    Chemotherapy; 1992 Dec; 38(1):28-35. PubMed ID: 1618001
    [Abstract] [Full Text] [Related]

  • 16. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
    García-Cobos S, Arroyo M, Pérez-Vázquez M, Aracil B, Lara N, Oteo J, Cercenado E, Campos J.
    J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.